Biogen’s Non-Opioid Pain Drug Shines in Small Fiber Neuropathy Study

, , , , , ,

Biogen reported positive topline results from the company’s Phase II CONVEY trial of vixotrigine for the treatment of small fiber neuropathy (SFN). 

Read more
/by